Where the regulatory community gathers to discuss the topics you want to learn, with expert speakers offering practical insights you can apply right away.
RAPS Convergence is the largest and most well-recognized annual gathering of regulatory affairs professionals and innovators worldwide. RAPS Convergence unites representatives from industry, global regulatory bodies, and research, academic, and clinical organizations that are directly involved in managing the regulatory process and aligning science, regulation, and business strategy.
RAPS Convergence is designed to educate and empower professionals about the ever-evolving healthcare product regulatory environment within an interactive forum that facilitates community exchange, connections, and knowledge sharing.
Regulatory and quality professionals assembled in the Queen City for three days of education, connection, and celebration of 50 years of regulatory affairs at RAPS Convergence 2026.
RAPS is excited and looking forward to gathering with the regulatory community in Minneapolis, MN, in 2027!
19-21 September 2027
18-19 September (Preconference Workshops)
Minneapolis Convention Center
Minneapolis, Minnesota, USA
You can help us shape next year’s agenda with hot topics in regulatory affairs. Join our email list to receive notifications about the 2027. Call for Proposals (expected to open in late 2026).

Sr. Director & Head of Global
Regulatory Intelligence
& Analysis, Pfizer

VP of Global Government Strategy,
Veeva MedTech

Director, Global Regulatory Affairs, Thermo Fisher Scientific

Vice President, Regulatory Affairs, Surgical & Interventional Solutions Division, Olympus Corporation

Founder, Regulatory Affairs Consultant and Writer, NOMSA Regulatory and Writing

Global Director Regulatory Strategy, TÜV SÜD Product Service GmbH

Director of Global Regulatory, Advertising & Promotion, Intuitive Surgical

Sr. Director, Reg Intelligence and Ad/Pro, Intutive Surgical

Independent Consultant, Speicher Regulatory Services

Director, Regulatory Affairs CMC, Moderna

Sr Director, Regulatory Policy and Intelligence, LEO Pharma

Director US Regulatory Policy, BioMarin Pharmaceutical

Co-founder and Principal, Pacific Horizon Biopharma Consulting

CEO & Founder, APS Pharma Solutions

Regulatory Affairs Lead, UCB Biopharma

Professor, Adjunct, Temple University, School of Pharmacy

Principal Consultant, Salditt Regulatory Consulting

Associate Director of Regulatory Programs
Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
Department of Health and Human Services

Principal Scientific Administrator, Stakeholders and Communication Division, European Medicines Agency